Bicara Therapeutics Inc BCAX IPO will take place September, 13 on the NASDAQ exchange under the ticker BCAX.
The company is offering shares at an expected price between $16.00 and $18.00 per share with an insider lock-up period of 180 days ending on March 12, 2025.
See also: Benzinga IPO Calendar
About Bicara Therapeutics Inc
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors
See also: Benzinga's Most Shorted Stocks
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
